Ascend Wellness Holdings, Inc. (OTC:AAWH - Get Free Report) saw a large increase in short interest in the month of August. As of August 15th, there was short interest totaling 14,100 shares, anincreaseof261.5% from the July 31st total of 3,900 shares. Based on an average daily volume of 818,600 shares, the short-interest ratio is presently 0.0 days. Based on an average daily volume of 818,600 shares, the short-interest ratio is presently 0.0 days.
Ascend Wellness Price Performance
OTC AAWH traded down $0.02 during trading hours on Monday, reaching $0.71. 22,678 shares of the company's stock were exchanged, compared to its average volume of 165,764. The stock has a market cap of $145.13 million, a PE ratio of -1.73 and a beta of 1.17. Ascend Wellness has a one year low of $0.26 and a one year high of $1.02. The firm has a fifty day moving average of $0.52 and a 200-day moving average of $0.40. The company has a current ratio of 1.47, a quick ratio of 0.80 and a debt-to-equity ratio of 2.61.
Analysts Set New Price Targets
Separately, Zacks Research upgraded Ascend Wellness to a "strong sell" rating in a research note on Tuesday, August 12th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company currently has an average rating of "Sell".
View Our Latest Analysis on Ascend Wellness
Ascend Wellness Company Profile
(
Get Free Report)
Ascend Wellness Holdings, Inc engages in the cultivation, manufacture, and distribution of cannabis consumer packaged goods in the United States. The company offers flower, pre-rolls, concentrates, vapes, edibles, tinctures, and other cannabis-related products under the Common Goods, SimplyHerb, Ozone, Ozone Reserve, Royale, Tunnel Vision, Miss Grass, Lowell Smokes, Edie Parker, 1906, and AiroPro brands.
Read More
Before you consider Ascend Wellness, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ascend Wellness wasn't on the list.
While Ascend Wellness currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.